Cross-Neutralization Potential of Native Human Papillomavirus N-Terminal L2 Epitopes
2011

Cross-Neutralization of Human Papillomavirus Types

publication Evidence: moderate

Author Information

Author(s): Conway Michael J., Cruz Linda, Alam Samina, Christensen Neil David, Meyers Craig

Primary Institution: The Pennsylvania State University College of Medicine

Hypothesis

Is cross-neutralization of other HPV types dependent on the time of tissue harvest?

Conclusion

The study found that multiple anti-L2 antibodies could cross-neutralize HPV16, HPV31, and HPV18, but HPV45 was resistant to neutralization.

Supporting Evidence

  • HPV16 L2 epitopes were only exposed in 20-day virions.
  • HPV31 and HPV18 L2 epitopes were exposed in 10-day virions.
  • HPV45 was not cross-neutralized by any of the anti-HPV16 L2 antibodies.

Takeaway

This study shows that some HPV types can be neutralized by antibodies, but others, like HPV45, cannot be neutralized at all.

Methodology

Neutralization assays were performed using antibodies against L2 epitopes from HPV types in organotypic cultures.

Limitations

The study did not explore the mechanisms behind the increased infectivity observed with some antibodies.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016405

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication